Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical advances in targeting epigenetics for cancer therapy
Shengrui Feng, Daniel D. De Carvalho
FEBS Journal (2021) Vol. 289, Iss. 5, pp. 1214-1239
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Enyong Dai, Zhi Zhu, Shudipto Wahed, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 187
Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy
Mehrdad Hashemi, Marzieh Sadat Moosavi, Hedyeh Maghareh Abed, et al.
Pharmacological Research (2022) Vol. 184, pp. 106418-106418
Closed Access | Times Cited: 110
Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential
Pei‐Suen Tsou, John Varga, Steven O’Reilly
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 10, pp. 596-607
Closed Access | Times Cited: 79
Overcoming acquired resistance to cancer immune checkpoint therapy: potential strategies based on molecular mechanisms
Bin Wang, Han Yin, Yuyu Zhang, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 33
Select EZH2 inhibitors enhance viral mimicry effects of DNMT inhibition through a mechanism involving NFAT:AP-1 signaling
Alison A. Chomiak, Rochelle L. Tiedemann, Yanqing Liu, et al.
Science Advances (2024) Vol. 10, Iss. 13
Open Access | Times Cited: 9
A comprehensive review of immune checkpoint inhibitors for cancer treatment
Md Aslam Hossain
International Immunopharmacology (2024) Vol. 143, pp. 113365-113365
Closed Access | Times Cited: 8
Epithelial–Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics
Luiz Paulo Chaves, Camila Morais Melo, Fabiano Pinto Saggioro, et al.
Genes (2021) Vol. 12, Iss. 12, pp. 1900-1900
Open Access | Times Cited: 48
Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies
Chitra Thakur, Yiran Qiu, Yao Fu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 35
Novel epigenetic therapeutic strategies and targets in cancer
Quratulain Babar, Ayesha Saeed, Tanveer A. Tabish, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 12, pp. 166552-166552
Open Access | Times Cited: 30
Understanding the function and regulation of Sox2 for its therapeutic potential in breast cancer
Ankita Dey, Moumita Kundu, Subhayan Das, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 2, pp. 188692-188692
Closed Access | Times Cited: 28
Caregivers with Cancer Patients: Focus on Hispanics
Jasbir Bisht, Priyanka Rawat, Ujala Sehar, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 626-626
Open Access | Times Cited: 18
SETDB1 as a cancer target: Challenges and perspectives in drug design
Haifa Hassanie, André Berndt Penteado, Larissa Costa de Almeida, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 5, pp. 1424-1451
Closed Access | Times Cited: 6
Epigenetic Therapies in Triple-Negative Breast Cancer: Concepts, Visions, and Challenges
Ulrich Lehmann
Cancers (2024) Vol. 16, Iss. 12, pp. 2164-2164
Open Access | Times Cited: 6
Epigenetic frontiers: miRNAs, long non-coding RNAs and nanomaterials are pioneering to cancer therapy
Rajkumar Prabhakaran, Rajkumar Thamarai, Sivabalan Sivasamy, et al.
Epigenetics & Chromatin (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 6
Targeting Tumor Microenvironment by Metal Peroxide Nanoparticles in Cancer Therapy
Simon N. Mbugua
Bioinorganic Chemistry and Applications (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 25
A comprehensive comparative study on LSD1 in different cancers and tumor specific LSD1 inhibitors
Jianshu Dong, Waqar Pervaiz, Bilal Tayyab, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114564-114564
Closed Access | Times Cited: 23
CRISPR/Cas9 Screen in Gastric Cancer Patient‐Derived Organoids Reveals KDM1A‐NDRG1 Axis as a Targetable Vulnerability
Jovan Mircetic, Aylin Camgöz, Moustafa Abohawya, et al.
Small Methods (2023) Vol. 7, Iss. 6
Closed Access | Times Cited: 16
Alteration in DNA methylation patterns: Epigenetic signatures in gastrointestinal cancers
Zahra Heydari, Farideh Moeinvaziri, Seyed Mohammad Ali Mirazimi, et al.
European Journal of Pharmacology (2024) Vol. 973, pp. 176563-176563
Closed Access | Times Cited: 5
Current trends in clinical trials and the development of small molecule epigenetic inhibitors as cancer therapeutics
Nazanin Zohourian, James A. L. Brown
Epigenomics (2024) Vol. 16, Iss. 9, pp. 671-680
Closed Access | Times Cited: 5
Designing HDAC-PROTACs: Lessons Learned So Far
Fabian Fischer, Leandro A. Alves Avelar, Laoise Murray, et al.
Future Medicinal Chemistry (2021) Vol. 14, Iss. 3, pp. 143-166
Open Access | Times Cited: 28
Anticancer mechanisms of phytochemical compounds: focusing on epigenetic targets
Nasreddine El Omari, Mohamed Bakha, Hamada Imtara, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 35, pp. 47869-47903
Closed Access | Times Cited: 27
Comprehensive Transcriptomic Analysis of Novel Class I HDAC Proteolysis Targeting Chimeras (PROTACs)
India M. Baker, Joshua P. Smalley, Khadija A Sabat, et al.
Biochemistry (2022) Vol. 62, Iss. 3, pp. 645-656
Open Access | Times Cited: 20
Epigenetic modulation of ferroptosis in cancer: Identifying epigenetic targets for novel anticancer therapy
Jaewang Lee, Jong‐Lyel Roh
Cellular Oncology (2023) Vol. 46, Iss. 6, pp. 1605-1623
Closed Access | Times Cited: 12
EpigenPlot: An interactive web platform for DNA methylation‐based biomarker and drug target discovery in colorectal cancer
Dalma Müller, Balázs Győrffy
British Journal of Pharmacology (2025)
Open Access
Isothiocyanates Enhance the Anti-Melanoma Effect of Zebularine Through Modulation of Apoptosis and Regulation of DNMTs’ Expression, Chromatin Configuration and Histone Posttranslational Modifications Associated with Altered Gene Expression Patterns
Ioannis Anestopoulos, Ioannis Paraskevaidis, Sotiris Kyriakou, et al.
Epigenomes (2025) Vol. 9, Iss. 1, pp. 7-7
Open Access
Page 1 - Next Page

Scroll to top